TET2 and acute myeloid leukemia: shRNA-mediated knockdown of TET2 in THP-1 AML cells (10, 11) conferred sensitivity to the growth-inhibitory effects of 5′-Aza (P = 0.005), though the phenotype was relatively weak (Supplemental Figure 9).